Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.

PubWeight™: 2.97‹?› | Rank: Top 1%

🔗 View Article (PMC 2598046)

Published in J Med Genet on September 08, 2006

Authors

E Rajcan-Separovic, C Harvard, X Liu, B McGillivray, J G Hall, Y Qiao, J Hurlburt, J Hildebrand, E C R Mickelson, J J A Holden, M E S Lewis

Articles citing this

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med (2011) 3.51

Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry (2008) 2.60

Novel microdeletion syndromes detected by chromosome microarrays. Hum Genet (2008) 1.90

2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features? J Med Genet (2008) 1.25

Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet (2008) 1.20

A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients. Eur J Hum Genet (2009) 1.20

Ethical implications of array comparative genomic hybridization in complex phenotypes: points to consider in research. Genet Med (2007) 1.16

Consistent chromosome abnormalities identify novel polymicrogyria loci in 1p36.3, 2p16.1-p23.1, 4q21.21-q22.1, 6q26-q27, and 21q2. Am J Med Genet A (2008) 1.12

Understanding the impact of 1q21.1 copy number variant. Orphanet J Rare Dis (2011) 1.11

BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations. J Clin Invest (2015) 1.07

Association of GTF2i in the Williams-Beuren syndrome critical region with autism spectrum disorders. J Autism Dev Disord (2012) 1.01

A newly recognised microdeletion syndrome of 2p15-16.1 manifesting moderate developmental delay, autistic behaviour, short stature, microcephaly, and dysmorphic features: a new patient with 3.2 Mb deletion. J Med Genet (2009) 0.97

Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics. Hum Genet (2010) 0.97

Long non-coding RNAs in neurodevelopmental disorders. Front Mol Neurosci (2013) 0.95

Submicroscopic deletions of 11q24-25 in individuals without Jacobsen syndrome: re-examination of the critical region by high-resolution array-CGH. Mol Cytogenet (2008) 0.93

Genome-wide linkage in Utah autism pedigrees. Mol Psychiatry (2009) 0.93

The facial dysmorphy in the newly recognised microdeletion 2p15-p16.1 refined to a 570 kb region in 2p15. J Med Genet (2008) 0.89

Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin. Curr Opin Genet Dev (2015) 0.87

Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1. PLoS One (2014) 0.83

miRNA and miRNA target genes in copy number variations occurring in individuals with intellectual disability. BMC Genomics (2013) 0.82

Further characterization of microdeletion syndrome involving 2p15-p16.1. Am J Med Genet A (2010) 0.81

2p15-p16.1 microdeletion syndrome: molecular characterization and association of the OTX1 and XPO1 genes with autism spectrum disorders. Eur J Hum Genet (2011) 0.80

BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription. Am J Hum Genet (2016) 0.79

Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications. Exp Neurobiol (2015) 0.78

Complex balanced chromosomal translocation t(2;5;13) (p21;p15;q22) in a woman with four reproductive failures. Mol Cytogenet (2014) 0.77

Chromosomal contacts connect loci associated with autism, BMI and head circumference phenotypes. Mol Psychiatry (2016) 0.77

Exome Sequencing of a Pedigree Reveals S339L Mutation in the TLN2 Gene as a Cause of Fifth Finger Camptodactyly. PLoS One (2016) 0.76

New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants. Ital J Pediatr (2016) 0.75

Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis. JCI Insight (2016) 0.75

Genetic Candidate Variants in Two Multigenerational Families with Childhood Apraxia of Speech. PLoS One (2016) 0.75

Effects of VRK2 (rs2312147) on white matter connectivity in patients with schizophrenia. PLoS One (2014) 0.75

Articles cited by this

The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord (2000) 37.47

Diagnostic genome profiling in mental retardation. Am J Hum Genet (2005) 8.60

Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet (2004) 6.90

Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet (2004) 5.76

Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet (2003) 5.43

Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med (1981) 4.25

The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet (1995) 4.25

Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet (2006) 3.70

Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet (2001) 3.28

Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet (2005) 3.11

3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet (2005) 2.38

Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet (2003) 2.15

Identification of disease genes by whole genome CGH arrays. Hum Mol Genet (2005) 1.85

Detection of submicroscopic deletions in band 17p13 in patients with the Miller-Dieker syndrome. Am J Hum Genet (1988) 1.83

Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genet (2005) 1.79

Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet A (2005) 1.68

The use of telomere probes to investigate submicroscopic rearrangements associated with mental retardation. Curr Opin Genet Dev (2003) 1.64

Quantifying the phenotype in autism spectrum disorders. Am J Med Genet (2001) 1.46

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood (2002) 1.38

Submicroscopic subtelomeric 1qter deletions: a recognisable phenotype? J Med Genet (2001) 1.38

Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis. Hum Mol Genet (2005) 1.37

BAC array CGH reveals genomic aberrations in idiopathic mental retardation. Am J Med Genet A (2006) 1.30

Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes. J Med Genet (2004) 1.22

Fryns syndrome phenotype caused by chromosome microdeletions at 15q26.2 and 8p23.1. J Med Genet (2005) 1.16

Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol (2005) 1.12

Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome. Eur J Hum Genet (2006) 1.11

15q duplication associated with autism in a multiplex family with a familial cryptic translocation t(14;15)(q11.2;q13.3) detected using array-CGH. Clin Genet (2006) 1.09

Molecular genetics of peroxisomal disorders. Front Biosci (2000) 1.05

An update on chromosome deletion and microdeletion syndromes. Curr Opin Pediatr (1998) 1.04

Genetic basis of peroxisome-assembly mutants of humans, Chinese hamster ovary cells, and yeast: identification of a new complementation group of peroxisome-biogenesis disorders apparently lacking peroxisomal-membrane ghosts. Am J Hum Genet (1998) 1.00

The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies. Int J Hematol (2003) 0.93

Leucodysplasia, microcephaly, cerebral malformation (LMC): a novel recessive disorder linked to 2p16. Brain (2005) 0.91

Interstitial deletion in Xp22.3 is associated with X linked ichthyosis, mental retardation, and epilepsy. J Med Genet (2000) 0.91

[A preliminary study to assess the value of the DNA chips SpectralChip to detect subtle constitutional chromosome imbalances]. Ann Biol Clin (Paris) (2004) 0.89

FISH detection of chromosome polymorphism and deletions in the spinal muscular atrophy (SMA) region of 5q13. Cytogenet Cell Genet (1996) 0.87

Articles by these authors

The sequence of the human genome. Science (2001) 101.55

The genome sequence of Drosophila melanogaster. Science (2000) 74.32

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (1997) 16.09

Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genet (2001) 13.05

Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell (1997) 12.83

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem (1999) 6.88

Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science (2001) 6.84

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1999) 4.90

International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet (1988) 4.84

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell (1995) 4.73

Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell (1991) 4.66

Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell (2000) 4.51

The sex-determining region of the human Y chromosome encodes a finger protein. Cell (1987) 4.43

Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31

SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol (2000) 4.30

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97

A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet (2000) 3.63

Statistical power and optimal design for multisite randomized trials. Psychol Methods (2000) 3.58

Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54

The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour. Proc R Soc Lond B Biol Sci (1969) 3.54

Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am J Physiol Regul Integr Comp Physiol (2003) 3.37

The immediate effect of antigens on the cell output of a lymph node. Br J Exp Pathol (1965) 3.16

Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release (2009) 3.08

CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene (2011) 3.08

The distal arthrogryposes: delineation of new entities--review and nosologic discussion. Am J Med Genet (1982) 3.06

Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol (1999) 3.01

The ultrastructure and function of the cells in lymph following antigenic stimulation. J Exp Med (1967) 2.98

Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science (2001) 2.97

Lead exposure and intelligence in 7-year-old children: the Yugoslavia Prospective Study. Environ Health Perspect (1997) 2.88

Intrinsic rhythmic propulsion of lymph in the unanaesthetized sheep. J Physiol (1965) 2.87

Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79

The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci U S A (2001) 2.75

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther (1999) 2.73

A transmission/disequilibrium test that allows for genotyping errors in the analysis of single-nucleotide polymorphism data. Am J Hum Genet (2001) 2.68

Studies on the lymphocytes of sheep. III. Destination of lymph-borne immunoblasts in relation to their tissue of origin. Eur J Immunol (1977) 2.61

Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology (2009) 2.60

Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev (1994) 2.54

The distribution and differentiation of lymph-borne immunoblasts after intravenous injection into syngeneic recipients. Cell Tissue Kinet (1972) 2.52

Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med (1980) 2.50

Assembly of Trp1 in a signaling complex associated with caveolin-scaffolding lipid raft domains. J Biol Chem (2000) 2.43

Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. Mol Endocrinol (1997) 2.34

Studies of the cells in the afferent and efferent lymph of lymph nodes draining the site of skin homografts. J Exp Med (1967) 2.31

Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J (1992) 2.29

Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev (1998) 2.29

An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet (1995) 2.26

The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol (2001) 2.25

Chromosome maps of man and mouse. IV. Ann Hum Genet (1989) 2.25

Noonan syndrome: the changing phenotype. Am J Med Genet (1985) 2.24

Familial insertional translocation of a portion of 3q into 11q resulting in duplication and deletion of region 3q22.1 leads to q24 in different offspring. Am J Med Genet (1981) 2.23

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene (2011) 2.22

Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J AAPOS (2000) 2.19

Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol (2012) 2.18

An epidemiological study of insomnia among the Japanese general population. Sleep (2000) 2.09

Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci (2001) 2.09

Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway. Oncogene (2007) 2.07

SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci U S A (1999) 2.06

Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem (2001) 2.06

Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci (2001) 2.05

Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry (2002) 2.05

Errors of morphogenesis: concepts and terms. Recommendations of an international working group. J Pediatr (1982) 2.04

Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly--a new syndrome? Part I: clinical, causal, and pathogenetic considerations. Am J Med Genet (1980) 2.02

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol (2003) 2.01

Social networks, social support, and mortality among older people in Japan. J Gerontol (1994) 2.01

Terathanasia, folic acid, and birth defects. Lancet (1997) 2.00

Predicting global atmospheric ice nuclei distributions and their impacts on climate. Proc Natl Acad Sci U S A (2010) 2.00

Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development (1999) 2.00

Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A (2004) 1.99

Genetic counseling for adoptees at risk for specific inherited disorders. Am J Med Genet (1980) 1.98

The cellular immune response to primary sarcomata in rats. I. The significance of large basophilic cells in the thoracic duct lymph following antigenic challenge. Proc R Soc Lond B Biol Sci (1969) 1.97

The frequency and financial burden of genetic disease in a pediatric hospital. Am J Med Genet (1978) 1.97

The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes (2004) 1.96

DOS, a novel pleckstrin homology domain-containing protein required for signal transduction between sevenless and Ras1 in Drosophila. Cell (1996) 1.94

Limb pterygium syndromes: a review and report of eleven patients. Am J Med Genet (1982) 1.91

Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol Cell (1999) 1.91

G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. Science (2001) 1.90

Reduced neurogenesis after neonatal seizures. J Neurosci (2001) 1.89

Molecular interactions between Vestigial and Scalloped promote wing formation in Drosophila. Genes Dev (1998) 1.89

The homing of lymph-borne immunoblasts to the small gut of neonatal rats. Transplantation (1972) 1.89

Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci U S A (1994) 1.88

Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation (2001) 1.88

Nanolitre liquid patterning in aqueous environments for spatially defined reagent delivery to mammalian cells. Nat Mater (2009) 1.87

The transport by hepatocytes of immunoglobulin A from blood to bile visualized by autoradiography and electron microscopy. Immunology (1979) 1.86

Efficient asymmetric synthesis of biologically important tryptophan analogues via a palladium-mediated heteroannulation reaction. J Org Chem (2001) 1.85

Improved dual-energy material discrimination for dual-source CT by means of additional spectral filtration. Med Phys (2009) 1.85

Deficiency in fatty acid synthase leads to premature cell death and dramatic alterations in plant morphology. Plant Cell (2000) 1.84

Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst (2001) 1.84

Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet (1995) 1.83

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol (1998) 1.82

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ (2009) 1.82

Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation (1999) 1.82

Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry (2000) 1.81

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med (1997) 1.81

Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci U S A (1997) 1.80

An invasive cleavage assay for direct quantitation of specific RNAs. Nat Biotechnol (2001) 1.79

A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem (2001) 1.77

The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell (2001) 1.76

Synaptotagmin VII as a plasma membrane Ca(2+) sensor in exocytosis. Neuron (2001) 1.76

Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol (2001) 1.75

Amyoplasia, the most common type of arthrogryposis: the potential for good outcome. Pediatrics (1996) 1.75